Biocept, Inc.Vice President, Translational Research and Clinical Development
Apr. 2011 - Aug. 2014Greater San Diego AreaSpecialize in assay development. Focused on management and leadership of the translational research team in optimizing and validating laboratory tests for commercialization through Biocept's CAP accredited CLIA lab. Major accomplishment: lead the team through successful laboratory validation of Biocept's first commercial oncology product, OncoCEE-BR, developed for targeted enumeration (based on cytokeratin staining) and characterization (based on HER2 by FISH, and ER/PR by ICC) of circulating tumor cells in women with metastatic breast cancer. Also the primary liaison and facilitator of several basic science and clinical research collaborations with investigators at MD Anderson Cancer Center.